Bibliographie (2362)
Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.
jeudi, 27 janvier 2022 11:57 Écrit par Zouhair SouissiEfficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant – New England Journal of Medicine Commentary: Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds – University of Wisconsin-Madison Commentary on Twitter Investigators assessed the in vitro activities of seven monoclonal antibodies & three antiviral drugs against […]
The post Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective. appeared first on Links Medicus.
Comprehensive review of chest tube management.
jeudi, 27 janvier 2022 10:53 Écrit par Zouhair SouissiComprehensive Review of Chest Tube Management – JAMA Surgery (free for a limited period)
The post Comprehensive review of chest tube management. appeared first on Links Medicus.
A registry study with 1,581 cases of Stenotrophomonas maltophilia blood and/or lower respiratory infections suggest Levofloxacin is a reasonable alternative to standard therapy with Trimethoprim-sulfamethoxazole.
mercredi, 26 janvier 2022 04:41 Écrit par Zouhair SouissiTrimethoprim-Sulfamethoxazole versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 U.S. Hospitals – Open Forum Infectious Diseases Commentary on Twitter A new study in OFID suggests that mortality outcomes are similar comparing levofloxacin and TMP/SMX treatment of S. maltophilia lower respiratory tract and bloodstream infections. ?:https://t.co/80QDy3DTU9 #IDSAJournals @PaulSaxMD @DrJLi @Keith_S_Kaye […]
The post A registry study with 1,581 cases of Stenotrophomonas maltophilia blood and/or lower respiratory infections suggest Levofloxacin is a reasonable alternative to standard therapy with Trimethoprim-sulfamethoxazole. appeared first on Links Medicus.
Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold.
mercredi, 26 janvier 2022 04:41 Écrit par Zouhair SouissiOral antihistamine‐decongestant‐analgesic combinations for the common cold – Cochrane Library Commentary: Oral antihistamine-decongestant-analgesic combinations for the common cold – Cochrane Library
The post Systematic Review: Oral antihistamine‐decongestant‐analgesic combinations for the common cold. appeared first on Links Medicus.
RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment.
mercredi, 26 janvier 2022 04:41 Écrit par Zouhair SouissiIn-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial – JAMA Network Open Commentary on Twitter In this 2-year study, data showed that electronic directly observed therapy (eDOT) was as effective as traditional in-person DOT for ensuring high adherence to treatment of tuberculosis disease. @CDC_TB @nycHealthy @ColumbiaMed https://t.co/yTrU1JRuwn pic.twitter.com/QXthE4d266 […]
The post RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment. appeared first on Links Medicus.
RCT: Acetazolamide prevents adverse altitude effects in COPD and healthy adults.
mercredi, 26 janvier 2022 04:41 Écrit par Zouhair SouissiAcetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults – NEJM Evidence Related: A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention
The post RCT: Acetazolamide prevents adverse altitude effects in COPD and healthy adults. appeared first on Links Medicus.
Cohort study: Among patients who survived ICU treatment for COVID-19, 75% still reported physical, mental, or cognitive symptoms after 1 year.
mercredi, 26 janvier 2022 04:41 Écrit par Zouhair SouissiClinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19 – JAMA Commentaries: 75% of COVID ICU survivors have physical symptoms 1 year on – CIDRAP Majority of COVID-19 survivors experience health problems one-year post ICU admission – News Medical
The post Cohort study: Among patients who survived ICU treatment for COVID-19, 75% still reported physical, mental, or cognitive symptoms after 1 year. appeared first on Links Medicus.
![[Preprint] Cohort study: Reduced risk of hospitalization associated with infection with SARS-CoV-2 Omicron relative to Delta.](/media/k2/items/cache/9ad7d231a57dcffaa99d5f95d8204ef3_S.jpg)
[Preprint] Cohort study: Reduced risk of hospitalization associated with infection with SARS-CoV-2 Omicron relative to Delta.
mardi, 25 janvier 2022 11:42 Écrit par Zouhair SouissiReduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort Study – SSRN / Preprints with The Lancet Commentaries: Danish report: lower risk of hospitalisation with Omicron – Copenhagen Post Omicron has a 36% lower risk for hospitalization compared to Delta: Denmark study – Outbreak News Today Commentary […]
The post [Preprint] Cohort study: Reduced risk of hospitalization associated with infection with SARS-CoV-2 Omicron relative to Delta. appeared first on Links Medicus.
![[Preprint] Omicron SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta.](/media/k2/items/cache/66a54350e94d9d93612885188af705a6_S.jpg)
[Preprint] Omicron SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta.
mardi, 25 janvier 2022 11:42 Écrit par Zouhair SouissiOmicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2) – medRxiv Commentary on Twitter In Portugal, Omicron hospitalizations were 75% reduced compared with Delta, risk adjusted. Vaccination reduced hospitalizations 84%, w/a booster 93%https://t.co/MvkfuF3mzx pic.twitter.com/zyk2INWNis — Eric Topol (@EricTopol) January 23, 2022
The post [Preprint] Omicron SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta. appeared first on Links Medicus.
ACP living, rapid review: risk for reinfection after SARS-CoV-2.
mardi, 25 janvier 2022 11:42 Écrit par Zouhair SouissiRisk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection – Annals of Internal Medicine Commentary on Twitter Risk for Reinfection After #SARSCoV2: previous infection reduced risk for reinfection by 87% (95% CI, 84% to […]
The post ACP living, rapid review: risk for reinfection after SARS-CoV-2. appeared first on Links Medicus.
